A single center letter describes lung transplantation in people living with HIV despite CD4 counts under 200 during evaluation, emphasizing prior viral suppression and clinical context when assessing ...

Objective This study aimed to evaluate the prevalence and predictors of cardiovascular disease (CVD), chronic kidney disease ...

Symbiotec Pharmalab files DRHP with SEBI for IPO aggregating up to Rs. 2,180 crore: Our Bureau, Bengaluru Tuesday, December 23, 2025, 16:40 Hrs [IST] Symbiotec Pharmalab a researc ...

A new study published in the journal of Nature Scientific Reports showed that in individuals with severe alcohol-associated ...

Plantar fasciitis (PF) is one of the most prevalent causes of heel pain, involving inflammation of the plantar fascia leading ...

Medical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and ...

The FDA approved depemokimab (Exdensur) as the first ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype, GSK announced.

Please provide your email address to receive an email when new articles are posted on . The COVID-adjusted annualized asthma exacerbation rate dropped by 46%. Mean cumulative oral corticosteroid dose ...

THURSDAY, Dec. 4, 2025 (HealthDay News) -- For adults with oral corticosteroid (OCS)-dependent severe uncontrolled asthma, tezepelumab can help to reduce OCS use, according to a study published online ...

A systematic review and meta-analysis evaluated the association between corticosteroid therapy, mortality, and infectious complications in adults with severe non-COVID-19 pneumonia or acute ...

Below please find summaries of new articles that will be published in the next issue of Annals of Internal Medicine. The summaries are not intended to substitute for the full articles as a source of ...